Personalized medicine has reached a crossroads where fundamental change is not only appealing but essential, write Klarissa Hoday, Francesca Boggio, and Aleksander Ruzicic.
Klarissa Hoday et al
Advertisement
Klarissa Hoday is Principal, Francesca Boggio is Principal, and Aleksandar Ruzicic is Partner at Executive Insight.
Articles by Klarissa Hoday et al
Advertisement
Latest Updated Articles
Personalized Medicine at a CrossroadsPublished: March 27th 2015 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Real-World Data Brings New Insights to Natural History of Disease Studies
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
4
Alkermes Reveals CEO Succession Plan Following Richard Pops’ Retirement Announcement
5